All cancer types
Results
Phase 3
This trial compared 3 different doses of aspirin to help stop cancer developing in people with .
The trial was supported by Cancer Research UK. It was open for people to join between 2014 and 2019. The team published the results in 2026
Recruitment start: 1 October 2014
Recruitment end: 31 March 2019
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Sir John Burn
Bayer Pharma AG
Cancer Research UK
NIHR Clinical Research Network: Genetics
Newcastle University
Newcastle upon Tyne Hospitals NHS Foundation Trust
This is Cancer Research UK trial number CRUK/12/039.
There is more information about this trial on the CaPP3 website.
Last reviewed: 04 Sept 2026
CRUK internal database number: 10517
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
